Roth, A. et al., “Effect of magnesium on restenosis after percutaneous transluminal coronary angioplasty: a clinical and angiographic evaluation in a randomized patient population,” European Heart Journal, vol. 15(9), 1994, pp. 1164-1173.* |
Chemical Abstracts 138:44639 (2002).* |
Medline Abstract, accession No. 2001681052 (2002).* |
Medline Abstract, accession No. 2002088281 (2002).* |
Medline Abstract, accession No. 2001408480 (2001).* |
Ravn, H. B. et al., “Early administration of intravenous magnesium inhibits arterial thrombus formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17(12), 1997, pp. 3620-3625.* |
www.americanheart.org, Angioplasty, Percutaneous Transluminal Coronary (PTCA), Mar. 23, 2001. |
S.D. Gertz et al., “Effect of Magnesium Sulfate on Thrombus Formation Following Partial Arterial Constriction: Complications for Coronary Vasospasm,” Magnesium, vol. 6, No. 5, pp. 225-235 (1987). |
H-D Claus, “Zur Frage der Wirksamkeit einer Thromboembolieprophylaxe durch Magnesium bei der Kontakttherapie von Portio- und Korpuskarzinomen der Uterus mit Gammastrahlern,” Strahlentherapie, vol. 135, No. 3, pp. 291-294 (1968). |
H.B. Ravn et al., “Magnesium Inhibits Platelet Activity—an infusion study in healthy volunteers,” Thrombosis and Haemostasis, vol. 75, No. 6, pp. 939-944 (1996). |
Michael Shecter et al., “Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease,” American Heart Journal, 140:212-218 (Aug., 2000). |
Vladimir Rukshin et al, “Intravenous Magnesium in Experimental Stent Thrombosis in Swine,” Arteriosclerosis, Thrombosis and Vascular Biology, 21:1544-1549 (Sep., 2001). |